SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹17 Cr | ₹14 Cr | ₹43 Cr | ₹12 Cr | ₹7.04 Cr |
What is the latest Total Current Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹7.04 Cr |
How is Total Current Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 22.12 | |
| Mar2024 | ₹14 Cr | -66.70 | |
| Mar2023 | ₹43 Cr | 243.46 | |
| Mar2022 | ₹12 Cr | 75.92 | |
| Mar2021 | ₹7.04 Cr | - | |
Compare Total Current Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹2,437.2 Cr | 2.1% | 33.5% | 102% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -2.5% | -4.7% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | -4% | 8.1% | 55.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.3% | 0.2% | 36.6% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -1.7% | -6.1% | -12% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | -0.2% | -4.4% | -10.2% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 2.1% |
33.5% |
102% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses